about
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like MechanismTransgenic Mouse Bioassay: Evidence That Rabbits Are Susceptible to a Variety of Prion IsolatesElements modulating the prion species barrier and its passage consequencesPost-translational modifications in PrP expand the conformational diversity of prions in vivoProduction of cattle lacking prion protein.Human prion protein sequence elements impede cross-species chronic wasting disease transmission.Prion replication without host adaptation during interspecies transmissions.Accelerated high fidelity prion amplification within and across prion species barriers.Perturbation of endoplasmic reticulum homeostasis facilitates prion replication.Vertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model.The controversial protein-only hypothesis of prion propagation.Exploring the risks of a putative transmission of BSE to new speciesIn vitro generation of infectious scrapie prions.Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.Susceptibility of European red deer (Cervus elaphus elaphus) to alimentary challenge with bovine spongiform encephalopathy.Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.Rabbits are not resistant to prion infectionUnfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis.Naturally prion resistant mammals: a utopia?A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.Cell-free propagation of prion strains.Reduction of prion infectivity in packed red blood cells.Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.Spontaneous generation of infectious prion disease in transgenic mice.In vitro studies of the transmission barrier.Animal models for testing anti-prion drugs.Animal models for prion-like diseases.An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein.The architecture of prions: how understanding would provide new therapeutic insights.Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.Protein misfolding cyclic amplification corroborates the absence of PrPSc accumulation in placenta from foetuses with the ARR/ARQ genotype in natural scrapie.The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.Characterization of mesenchymal stem cells in sheep naturally infected with scrapie.Lactogenic immunity in transgenic mice producing recombinant antibodies neutralizing coronavirus.Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.Soluble polymorphic bank vole prion proteins induced by co-expression of quiescin sulfhydryl oxidase in E. coli and their aggregation behaviorsSheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.Prion-resistant or prion-susceptible species, this is the question.
P50
Q21284823-AD237DC4-6314-4656-9571-C223830984CFQ27318898-6631123C-0B64-4907-85C0-7DD4B95EC2BDQ28540614-456514DF-13F3-49A1-9D34-156ABC899909Q30399619-46D23D0A-CB80-49A6-9E19-F66308AAF9ADQ30492928-7D4F6760-E50F-43DF-9924-DAB32CDB9C1BQ30639674-9187B5CE-D9A8-441A-90C8-F401ED560B6DQ31155113-642E7EB7-A96D-4831-BD22-BC96CBFF2BF3Q33366539-CD0D199B-0C86-4985-AB01-8E121490FA4BQ33581647-DBBE1AD5-5B05-4871-8B10-9A2F5C8177EFQ33843366-1688E0CB-1F53-4264-8BA4-2BB2A13A4BC6Q34335604-4077C4C6-12B4-401F-9C32-BA283CFC24ABQ34362499-874B93AA-9B41-488A-AFCD-9E6E28E71CEBQ34413661-5979D05A-4D8C-4082-82AC-B082A102C93FQ34539336-206B3415-1AD7-45BF-86CE-B5DBAF7AF45BQ35007270-B2EEC0E9-6789-48B5-98DF-AE353EEE0673Q35826534-BCAB86B9-013F-4EA1-8C0E-6591EDCE08E6Q35882420-1D1C170B-75B0-4FBF-A99B-825A0786A836Q36393034-CF6BB09A-EBBA-46CA-9AC7-3B6A21CC2353Q36436198-9FEADE6E-EC4F-44E1-BA5B-DCC5771364ACQ36686430-84474439-1B51-467E-8750-D734A8E6662CQ36936923-22B95C34-2691-489B-82D7-F3A145B0ADC3Q37022481-E84C6470-A639-42E3-AC45-8FCFE1948075Q37339448-D91F08F3-01E8-4319-A999-05F5D1F1368BQ37343768-C6E43EF8-50C6-4CFE-A6F9-53F8E3A39D66Q37653878-05347F58-9566-446A-BA33-7EF3C2E89760Q38140995-F13C9A1B-6B31-4484-806A-A074EC0A9789Q38439914-9298623C-6554-4B4C-9CA6-01CFAC42DB22Q38634933-4A8C3AA5-2128-4B7E-9361-F0452558B7AEQ38967674-853DD579-9D02-4AAA-8C7B-EF9B697258D4Q39962425-569748DB-1FD6-4E80-9622-9182C132B24BQ40075626-2BECFEE0-5AD8-4AC0-83B6-935A19829D96Q40170687-9E1E5B15-6FAD-4DF1-9334-10B8AFC9814EQ40445820-89269980-E88E-46B4-A5F3-C5DB0155EC4FQ40968377-D078A693-FCC7-414C-B9BC-A7C7364AFF16Q41001210-E4C11E01-CA83-431F-AAD8-DA2E2A3A0605Q41842760-1B9E401E-DFCD-4BC0-9BC9-A3146A667959Q41924189-B67C2944-9ACA-4A32-BE34-D0CA3348F02FQ41924334-461BA7FA-796A-4701-A9DB-DCF5B9F488AEQ42957132-ABA6906B-D07E-476E-BDE3-7FD16C9C17F9Q43093548-FBA00855-4643-4E42-94DB-7E5F565B4E00
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
JOAQUÍN CASTILLA
@ast
JOAQUÍN CASTILLA
@en
JOAQUÍN CASTILLA
@es
JOAQUÍN CASTILLA
@nl
type
label
JOAQUÍN CASTILLA
@ast
JOAQUÍN CASTILLA
@en
JOAQUÍN CASTILLA
@es
JOAQUÍN CASTILLA
@nl
prefLabel
JOAQUÍN CASTILLA
@ast
JOAQUÍN CASTILLA
@en
JOAQUÍN CASTILLA
@es
JOAQUÍN CASTILLA
@nl
P1053
D-5261-2011
P106
P1153
8851950500
P31
P496
0000-0002-2216-1361